May 16 - 18, 2024 Brasilia - Brazil

Simultaneous Room


8:10 am – 8:38 am

Commented poster session 1



8:10 am – 8:13 am

Immediate postoperative complications associated with sentinel lymph node biopsy in early breast cancer in the context of the Sentinel Lymph Node Biopsy versus no Axillary Surgery in Early Breast Cancer Clinically and Ultrasonographically node negative (VENUS) Trial

8:13 am – 8:16 am

Breast cancer and local therapy: breast conservation and oncoplastic surgery are associated with improved quality of life

Daniel Meirelles Barbalho (BRA)

8:16 am – 8:19 am

CK19 expression and prognosis in women with breast cancer

Silvia Helena Rabelo dos Santos (BRA)

8:19 am – 8:22 am

Forequarter amputation in patients with breast cancer: a systematic literature review

René Aloisio da Costa Vieira (BRA)

8:22 am – 8:25 am

The Potential Role of Cavity Margins Sampling Shaving (CMSH) to Predict Complete Tumor Resection by Vacuum Assisted Excision (VAE)

Henrique Lima Couto (BRA)

8:25 am – 8:28 am

Is axillary evaluation still necessary in DCIS?

Marcellus do Nascimento Moreira Ramos (BRA)

8:28 am – 8:38 am


8:40 am – 9 am

Mini conference: How can the quality of the pathology study affect the treatment of breast cancer patients?



9 am – 9:10 am


9:10 am – 9:30 am

Mini conference: Breastfeeding after breast cancer



9:30 am – 9:40 am


10:30 am – 11 am

Commented poster session 2



10:30 am – 10:33 am

Factors influencing the engagement of Community Health Workers in breast cancer screening: Itaberaí Project

10:33 am – 10:36 am

Assessment of a continuing education program for Community Health Workers for breast cancer screening: Itaberaí Project

10:36 am – 10:39 am

Variant analysis in the TP53 gene for families in the state of Goiás with suspected Li-Fraumeni Syndrome: tool for early diagnosis and prevention of breast cancer

10:39 am – 10:42 am

Diagnostic accuracy study of magnetic resonance breast spectroscopy

10:42 am – 10:45 am

Suspicious mammographic findings out of the age range recommended by Brazilian Ministry of Health

10:45 am – 10:48 am

Gastrin-Releasing Peptide Receptor (GRPR) as a promising prognostic biomarker in breast cancer

Martina Lichtenfels (BRA)

10:48 am – 10:58 am


11 am – 11:20 am

Mini conference: Telemedicine and breast cancer



11:20 am – 11:40 am


11:40 am – 12 pm

Mini conference: What would I like and not like to hear from a healthcare professional as a patient?



12 pm – 12:10 pm


12:10 pm – 12:50 pm

BD Symposium – Tumor Board: minimally invasive breast treatment



2 pm – 2:30 pm

Commented poster session 3



2 pm – 2:03 pm

Characterization of an epigenetic regulatory network on basal-like breast cancer subtype and its impact on signaling pathways and biological processes

2:03 pm – 2:06 pm

Understanding and Adherence Level of Community Health Workers (CHW) to breast cancer screening according to the protocol established in the Itaberaí Project

2:06 pm – 2:09 pm

The role of tumor-associated macrophages in the prediction of sentinel lymph node involvement in breast cancer

Aline Carvalho Rocha (BRA)

2:09 pm – 2:12 pm

Evaluation of Tumor Infiltrating Lymphocytes as a predictive biomarker of recurrence in patients with Ductal Carcinoma In Situ of the breast

2:12 pm – 2:15 pm

The alarming level of sexual dysfunction among Brazilian women with early breast cancer undergoing adjuvant endocrine therapy

Daniele Assad Suzuki (BRA)

2:15 pm – 2:18 pm

Does the intrinsic chemoresistance profile modulate the efficacy of neoadjuvant chemotherapy in breast cancer patients?

Martina Lichtenfels (BRA)

2:18 pm – 2:28 pm


2:30 pm – 2:50 pm

Mini conference: Physiotherapy during chemotherapy infusion: why and how?



2:50 pm – 3 pm


2:30 pm – 2:50 pm

Commented poster session 4



3 pm – 3:03 pm

Analysis of the magee 3 equation for assessing prognosis in breast cancer treatment

3:03 pm – 3:06 pm

Integrated health technological solution for the resolution of breast cancer screening actions: Itaberaí Project

3:06 pm – 3:09 pm

Evaluation of the endometrium of women who used tamoxifen: correlation between ultrasonographic, hysteroscopic and histological findings

Clécio Ênio Murta de Lucena (BRA)

3:09 pm – 3:12 pm

Evaluation of pathological complete response in axilla in patients with triple negative breast cancer and pathological complete response in breast: a systematic review

3:12 pm – 3:15 pm

Capivasertib and fulvestrant, a new salvation for hormone receptor-positive breast cancer? A systematic review

3:15 pm – 3:18 pm

Scenario of breast reconstruction in the unified health system in Brazil

Darley de Lima Ferreira Filho (BRA)

3:18 pm – 3:28 pm


3:30 pm – 3:50 pm

Mini conference: Strategies to increase patient adherence to hormone therapy



3:50 pm – 4 pm


4 pm – 4:30 pm

Coffee Break

6:30 pm – 8:30 pm AI – ONCOLOGY INSIGHT


6:30 pm – 6:50 pm

Introduction to AI

6:50 pm – 6:55 pm

Question session

6:55 pm – 7:15 pm

Application of AI in medicine

7:15 pm – 7:20 pm

Question session

7:20 pm – 7:40 pm

Practical application of AI in Oncology

7:40 pm – 8:15 pm


8:15 pm – 8:25 pm

Introduction to Voida and Voida Pro

8:25 pm – 8:30 pm

Question session

8:30 pm